1-3 of 3
Takeshi Morii
Close
Sort by
Journal Articles

Phase 2 Study of FLAGM (Fludarabine+High-Dose Ara-C +G-CSF+Mitoxantrone) for Relapsed or Refractory Acute Myeloid Leukemia (AML): A Report From the Japan Adult Leukemia Study Group (JALSG).

Shuichi Miyawaki, MD, PhD, Naoko Hatsumi, MD, Takahiro Yamauchi, MD, Kousuke Tsuboi, MD, Atsushi Fujieda, MD, Akihiro Takeshita, MD, Norio Komatsu, MD, Noriko Usui, MD, Yukihiro Arai, MD, Fumihiro Ishida, MD, PhD, Takeshi Morii, MD, Yasuhiko Kano, MD, Michinori Ogura, MD, PhD, Noriko Doki, MD, Kazunori Ohnishi, MD, Tomoki Naoe, MD, Ryuzo Ohno, MD
Journal: Blood
Blood (2009) 114 (22): 1058.
https://doi.org/10.1182/blood.V114.22.1058.1058
Published: 2009
Journal Articles

Contribution of HLA Incompatibility on Clinical Outcomes of CBT in Patients with MDS Including Secondary AML in Japan: Multivariate Analysis Using Competing Risk Regression Model

Satoshi Takahashi, MD, Takuhiro Yamaguchi, PhD, Maki Monna-Ooiwa, Shuichi Taniguchi, MD, Hisashi Sakamaki, MD, PhD, Takeshi Morii, MD, Yoshihisa Nagatoshi, MD, Nobuyuki Aotsuka, MD, Shunichi Kato, MD, Minoko Takanashi, MD, Tokiko Nagamura, MD, Hiroshi Azuma, PhD, Shunro Kai, MD, Koji Kato, MD, Shigetaka Asano, MD
Journal: Blood
Blood (2008) 112 (11): 3004.
https://doi.org/10.1182/blood.V112.11.3004.3004
Published: 2008
Journal Articles

Reduced-Intensity Unrelated Cord Blood Transplantation (RICBT) in Adult Patients with High-Risk Hematological Malignancies.

Takeshi Morii, Itsuto Amano, Haruyuki Tanaka, Toshihiro Takahashi, Hiroshi Kimura
Journal: Blood
Blood (2005) 106 (11): 5433.
https://doi.org/10.1182/blood.V106.11.5433.5433
Published: 2005